Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01679184 · ClinicalTrials.gov registry record
XM-One Study for Living Donor Program
A clinical trial, sponsored by University of Miami.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01679184 is a clinical trial that was terminated before completion, run by University of Miami. The registered enrollment target is 4 participants.
The verdict
NCT01679184 was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Donor-Specific Antibody (DSA) (HLA) levels and non-HLA antibody levels in recipients prior to living kidney transplantation and randomize these individuals into a desensitization protocol in order to evaluate shifts that can occur with the Luminex and XM-One assay after treatment and up to 6 months post transplant. If desensitization is needed prior to transplantation in individuals with a negative crossmatch but positive DSA and/or XM-one - patients will be evaluated clinically with routine lab tests (serum creatinine levels, spot urine protein and spot urine creatinine levels) as well as protocol biopsy evaluations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01679184
The ClinicalTrials.gov registry entry for NCT01679184 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01679184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01679184 about?
NCT01679184 is a clinical study titled "XM-One Study for Living Donor Program". Donor-Specific Antibody (DSA) (HLA) levels and non-HLA antibody levels in recipients prior to living kidney transplantation and randomize these individuals into a desensitization protocol in order to evaluate shifts that can occur with the Luminex and XM-One assay after treatment and up to 6 months ...
What is the current status of trial NCT01679184?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2013-06. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT01679184?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.